SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-011373
Filing Date
2019-04-11
Accepted
2019-04-11 16:21:06
Documents
11
Period of Report
2019-05-22
Effectiveness Date
2019-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2019 FILING TNDM tndm-def14a_20190522.htm DEF 14A 1919617
2 GRAPHIC gtkki03ssgan000002.jpg GRAPHIC 4664
3 GRAPHIC gtkki03ssgan000007.jpg GRAPHIC 1919
4 GRAPHIC gtkki03ssgan000005.jpg GRAPHIC 8319
5 GRAPHIC gtkki03ssgan000008.jpg GRAPHIC 43749
6 GRAPHIC gtkki03ssgan000004.jpg GRAPHIC 8203
7 GRAPHIC gtkki03ssgan000006.jpg GRAPHIC 10010
8 GRAPHIC gtkki03ssgan000010.jpg GRAPHIC 73683
9 GRAPHIC gtkki03ssgan000009.jpg GRAPHIC 36583
10 GRAPHIC gtkki03ssgan000001.jpg GRAPHIC 57292
11 GRAPHIC gtkki03ssgan000003.jpg GRAPHIC 1919
  Complete submission text file 0001564590-19-011373.txt   2261388
Mailing Address 11075 ROSELLE STREET San Diego CA 92121
Business Address 11075 ROSELLE STREET San Diego CA 92121 858-366-6900
TANDEM DIABETES CARE INC (Filer) CIK: 0001438133 (see all company filings)

IRS No.: 204327508 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36189 | Film No.: 19744078
SIC: 3841 Surgical & Medical Instruments & Apparatus